Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 28, which means every article in Clinical Investigation has got 28 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

• Ricotti V, Jägle H, Theodorou M, Moore AT, Muntoni F, Thompson DA.(2016) Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system. European Journal of Human Geneticsx ;24:562-568. View at Publisher | View at Google Scholar | View at Indexing
• Goemans NM, Tulinius M, van den Hauwe M, Kroksmark AK, Buyse G.,et.al.. (2016) Long-term efficacy, safety, and pharmacokinetics of drisapersen in Duchenne muscular dystrophy: results from an open-label extension study. PloS one ;11:e0161955. View at Publisher | View at Google Scholar | View at Indexing
• Li Y, Zhang S, Zhang X, Li J, Ai X, Zhang L, Yu D, Ge S, Peng Y, Chen X. (2014) Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy. Cardiovascular research ;103:60-71. View at Publisher | View at Google Scholar | View at Indexing
• Heslop E, Csimma C, Straub V, McCall J, Nagaraju K, Wagner KR, Caizergues D, Korinthenberg R, Flanigan KM, Kaufmann P, McNeil E. (2015)The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet journal of rare diseases ;10:49. View at Publisher | View at Google Scholar | View at Indexing
• Geirs DP, Pottegård A, Halldórsson M, Zoëga H (2014 ) A Nationwide Study of Attentionâ€ÂDeficit/Hyperactivity Disorder Drug Use among Adults in Iceland 2003–2012. Basic & clinical pharmacology & toxicology 115: 417-422. View at Publisher | View at Google Scholar | View at Indexing
• Geirs DP, Pottegård A, Halldórsson M, Zoëga H (2014) A Nationwide Study of ADHD Drug Use among Adults in Iceland 2003-2012 . View at Publisher | View at Google Scholar | View at Indexing

• Oonk S, Spitali P, Hiller M, Switzar L, Dalebout H, Calissano M, Lochmüller H, Aartsma‐Rus A, Hoen P, Burgt YE.(2016) Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients. PROTEOMICS-Clinical Applications ;10:290-299.

  View at Publisher | View at Google Scholar
• Ricotti V, Muntoni F, Voit T.(2015) Challenges of clinical trial design for DMD. Neuromuscular Disorders ;25:932-935. View at Publisher | View at Google Scholar | View at Indexing
• Weimer K, Enck P (2014) Traditional and innovative experimental and clinical trial designs and their advantages and pitfalls. InPlacebo 237-272. View at Publisher | View at Google Scholar | View at Indexing

• Fischer D, Hafner P, Rubino D, Schmid M, Neuhaus C, Jung H, Bieri O, Haas T, Gloor M, Fischmann A, Bonati U. (2016) The 6-minute walk test,motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study. Neuromuscular Disorders ;26:414-422.

  View at Publisher | View at Google Scholar
• Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, et al. (2015) Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. International psychogeriatrics 27: 2059-2067. View at Publisher | View at Google Scholar | View at Indexing
• Hafner P, Bonati U, Rubino D, Gocheva V, Zumbrunn T, Gueven N, Fischer D.(2016) Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial. Trials ;17:389. View at Publisher | View at Google Scholar | View at Indexing
• Iovieno N, Nierenberg AA, Parkin SR, Kim DJ, Walker RS, et al. (2016 ) Relationship between placebo response rate and clinical trial outcome in bipolar depression. Journal of psychiatric research 74: 38-44. View at Publisher | View at Google Scholar | View at Indexing
• Wei Y, Speechley K, Campbell C.(2015) Health-Related Quality of Life in Children with DuchenneMuscular Dystrophy: A Review. Journal of Neuromuscular Diseases;2:313-324. View at Publisher | View at Google Scholar | View at Indexing
• Wang JJ, Ivanova A (2014 ) Dose finding with the sequential parallel comparison design. Journal of biopharmaceutical statistics 24: 1091-1101. View at Publisher | View at Google Scholar | View at Indexing
• Soto M, Abushakra S, Cummings J, Siffert J, Robert P, et al. (2015) Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer’s Disease: Focus on Agitation and Aggression. A Report from the EU/US/CTAD Task Force. The journal of prevention of Alzheimer's disease 2:184. View at Publisher | View at Google Scholar | View at Indexing
• Rosenkranz GK (2016) Remarks on designs enriching for placebo non-responders. Clinical Trials 13: 338-343. View at Publisher | View at Google Scholar | View at Indexing
• Silverman RK, Ivanova A (2017 ) Sample size re-estimation and other mid-course adjustments with sequential parallel comparison design. Journal of Biopharmaceutical Statistics. View at Publisher | View at Google Scholar | View at Indexing
• Wilsey B, Deutsch R, Marcotte TD ( 2016 ) Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids. Cannabis and Cannabinoid Research 1: 139-148. View at Publisher | View at Google Scholar | View at Indexing
• Ivanova A, Zhang Z, Thompson L, Yang Y, Kotz RM, et al. (2016 ) Can sequential parallel comparison design and two-way enriched design be useful in medical device clinical trials?. Journal of Biopharmaceutical Statistics 26: 167-177. View at Publisher | View at Google Scholar | View at Indexing
• Toniolo RA (2016) Ensaio clínico randomizado, duplo-cego, controlado com placebo, de monoidrato de creatina como terapia adjuvante na depressão bipolar (Doctoral dissertation, Universidade de São Paulo). View at Publisher | View at Google Scholar | View at Indexing
• Malheiros SR, Ribeiro DC, Alvarez MP, de Freitas BL, et.al. (2015)Motor Learning in Duchenne Muscular Dystrophy, a Literature Review. International Archives of Medicine;8. View at Publisher | View at Google Scholar | View at Indexing
• da Silva TD, de Oliveira EP, Balbino GC, de Souza JM, Capelini CM, Guarnieri R, de Abreu Lc.,et.al. Pegboard task in Duchenne muscular dystrophy. HealthMED.:365. View at Publisher | View at Google Scholar | View at Indexing
• Bushby K. (2015) Looking forward to new therapies: a personal perspective on the translational landscape for muscular dystrophies. Journal of Neuromuscular Diseases;2:S83. View at Publisher | View at Google Scholar | View at Indexing
• López Villar E, Wu D, Cho WC, Madero L, Wang X (2014) Proteomicsâ€Âbased discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities. Journal of cellular and molecular medicine 18: 1239-1246. View at Publisher | View at Google Scholar | View at Indexing
• Doussau A, Geoerger B, Jiménez I, Paoletti X (2016 ) Innovations for phase I dose-finding designs in pediatric oncology clinical trials. Contemporary clinical trials. 47: 217-227. View at Publisher | View at Google Scholar | View at Indexing
• Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L, Heberer K, McDonald CM, Sussman M.(2016) Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?. PLoS Currents ;8. View at Publisher | View at Google Scholar | View at Indexing

• Lewis LM, Graffeo C, Crosley P, Klausner HA, Clark CL, et al. (2015 ) Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor–induced angioedema: a multicenter, randomized, controlled trial. Annals of emergency medicine 65: 204-213.

  View at Publisher | View at Google Scholar
• Mercuri E, Baranello G, Battini R, Berardinelli A, Bertini E.,et.al..(2016) Registries versus tertiary care centers. Neuromuscular Disorders ;26(4-5):261-3. View at Publisher | View at Google Scholar | View at Indexing
• Craig TJ, Li HH, Riedl M, Bernstein JA, Lumry WR, et al. (2015 ) Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. The Journal of Allergy and Clinical Immunology: In Practice 3: 206-212. View at Publisher | View at Google Scholar | View at Indexing
• Fischer D, Hafner P, Rubino D, Schmid M. The 6-minute walk test, motor function measure and quantitative thigh. Imaging ;38:619-624. View at Publisher | View at Google Scholar | View at Indexing
• Bernstein JA, Moellman JJ, Collins SP, Hart KW, Lindsell CJ ( 2015 ) Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor–induced angioedema in the emergency department. Annals of Allergy, Asthma & Immunology 114: 245-249. View at Publisher | View at Google Scholar | View at Indexing

• Travlos V, Patman S, Wilson A, Simcock G, Downs J.(2016) Quality of life and psychosocial wellbeing in youth with neuromuscular disorders who are wheelchair users: A systematic review. Archives of Physical Medicine and Rehabilitation.

  View at Publisher | View at Google Scholar

• Shklyar I. Electrical Impedance Myography And Quantitative Ultrasound As Biomarkers In Duchenne Muscular Dystrophy.

  View at Publisher | View at Google Scholar
• Pelentsov LJ, Fielder AL, Esterman AJ (2016 ) The supportive care needs of parents with a child with a rare disease: a qualitative descriptive study. Journal of pediatric nursing 31: e207-e218. View at Publisher | View at Google Scholar | View at Indexing
• Vahedi L, Jabarpoor-Bonyadi M, Ghojazadeh M, Hazrati H, Rafeey M (2016) Association between outcomes and demographic factors in an Azeri Turkish population with cystic fibrosis: a cross-sectional study in Iran from 2001 through . Iranian Red Crescent Medical Journal 18. View at Publisher | View at Google Scholar | View at Indexing
• Goemans N, Vanden Hauwe M, Signorovitch J, Swallow E, Song J. (2016) Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy. PloS one;11:e0164684. View at Publisher | View at Google Scholar | View at Indexing
• Dunn AL (2016) Mapping Patient and Caregiver Involvement across the Orphan Drug Lifecycle and in Programs that Provide Access to Promising Therapies While Ensuring Prudent use of Scarce Health Care Resources (Doctoral dissertation, University of Alberta). View at Publisher | View at Google Scholar | View at Indexing
• Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, et al. (2016) The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Survey of ophthalmology 61: 1-7. View at Publisher | View at Google Scholar | View at Indexing
• Pigula AJ, Wu JS, Gilbertson MW, Darras BT, Rutkove SB, Anthony BW. (2016) Force-controlled ultrasound to measure passive mechanical properties of muscle in Duchenne muscular dystrophy. InEngineering in Medicine and Biology Society (EMBC), 2016 IEEE 38th Annual International Conference IEEE.. 2865-2868 View at Publisher | View at Google Scholar | View at Indexing

• Olga Ceron MD, FACR CS (2011) Recent Advances in Uveitic Glaucoma. Ophthalmology 26: 4-5.

  View at Publisher | View at Google Scholar
• Koppaka S, Shklyar I, Rutkove SB, Darras BT, Anthony BW, Zaidman CM, Wu JS. (2016) Quantitative Ultrasound Assessment of Duchenne Muscular Dystrophy Using Edge Detection Analysis. Journal of Ultrasound in Medicine;35:188918-97. View at Publisher | View at Google Scholar | View at Indexing
• Taheri T, Seyed N, Mizbani A, Rafati S ( 2016 ) Leishmania-based expression systems. Applied microbiology and biotechnology 100: 7377-7385. View at Publisher | View at Google Scholar | View at Indexing
• Seyed N, Taheri T, Rafati S (2016) Post-Genomics and Vaccine Improvement for Leishmania. Frontiers in microbiology 7. View at Publisher | View at Google Scholar | View at Indexing
• Hogarth MW. α-Actinin-3: a novel genetic modifier of duchenne muscular dystrophy. View at Publisher | View at Google Scholar | View at Indexing
• Keating GM (2015 ) Aflibercept: A Review of Its Use in Diabetic Macular Oedema. Drugs 75: 1153-1160. View at Publisher | View at Google Scholar | View at Indexing
• Silverstein CA. A Patient-Report Registry to Study Outcomes in a Rare Genetic Disease: DuchenneConnect. View at Publisher | View at Google Scholar | View at Indexing
• Rutkove SB, Kapur K, Zaidman C, Wu JS, Pasternak A, Madabusi L, et.al,. Electrical impedance myography for assessment of Duchenne muscular dystrophy. Annals of Neurology. View at Publisher | View at Google Scholar | View at Indexing
• Goemans N, Tulinius M, Kroksmark AK, Wilson R, van den Hauwe M, Campion G. (2016) Comparison of ambulatory capacity and disease progression of duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids. Neuromuscular Disorders. View at Publisher | View at Google Scholar | View at Indexing

• Teng T, Xu S, Chen Q, Chen F, Li X, et al. (2016) iegesbeckia pubescens ameliorates experimental ulcerative colitis in rats by modulating PPARγ. Int J Clin Exp Med 23082-23091.

  View at Publisher | View at Google Scholar